Clinically-Staged T3N0 Rectal Cancer: Is Preoperative Chemoradiotherapy the Optimal Treatment?
- Raffaele Lombardi MD,
- Dajana Cuicchi MD,
- Carmine Pinto MD,
- Francesca Di Fabio MD,
- Bruno Iacopino MD,
- Stefano Neri MD,
- Maria Lucia Tardio MD,
- Claudio Ceccarelli PhD,
- Ferdinando Lecce MD,
- Giampaolo Ugolini MD,
- Sara Pini MD,
- Piergiorgio Di Tullio MD,
- Mario Taffurelli MD,
- Francesco Minni MD,
- Andrea Martoni MD,
- Bruno Cola MD, FACS
- … show all 16 hide
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Preoperative chemoradiotherapy has been widely adopted as the standard of care for stage II–III rectal cancers. However, patients with T3N0 lesions had been shown to have a better prognosis than other categories of locally advanced tumor. Thus, neoadjuvant chemoradiation is likely to be overtreatment in this subgroup of patients. Nevertheless, the low accuracy rate of preoperative staging techniques for detection of node-negative tumors does not allow to check this hypothesis. We analyzed a group of patients with cT3N0 low rectal cancer who underwent neoadjuvant chemoradiotherapy with the purpose of evaluating the incidence of metastatic nodes in the resected specimens.
Between January 2002 and February 2008, 100 patients with low rectal cancer underwent clinical staging by means of endorectal ultrasound, computed tomography, positron emission tomography, and magnetic resonance imaging. All patients received preoperative 5-fluorouracil-based chemoradiotherapy and surgical resection with curative aim.
Of 100 patients with locally advanced rectal cancer, 32 were clinically staged as T3N0M0. Pathological analysis showed the presence of lymph node metastases in nine patients (28%) (node-positive group). In the remaining 23 cases, clinical N stage was confirmed at pathology (node-negative group). Node-positive and node-negative groups differ only in the number of ypT3 tumors (P < .01).
Our results indicate that immediate surgery for patients with cT3N0 rectal cancer represents an undertreatment risk in at least 28% of cases, making necessary the use of postoperative chemoradiotherapy. Preoperative chemoradiotherapy should be the therapy of choice on the grounds of the principle that overtreatment is less hazardous than undertreatment for cT3N0 rectal cancers.
- NIH consensus conference: adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990;264:1444–50.
- Heald RJ, Moran BJ, Ryall RDH, et al. Rectal cancer. The Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg. 1998;133:894–9. CrossRef
- Martling AL, Holm T, Rutqvist LE, et al. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm: Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet. 2000;356:93–6. CrossRef
- Kapeitejn E, Putter H, van de Velde CJ; Cooperative investigators of the Dutch ColoRectal Cancer Group. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in the Netherlands. Br J Surg. 2002;89:1142–9. CrossRef
- Enker WE, Thaler HT, Cranor ML, Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg. 1995;181:335–46.
- Simunovic M, Sexton R, Rempel E, Moran BJ, Heald RJ. Optimal preoperative assessment and surgery for rectal cancer may greatly limit the need for radiotherapy. Br J Surg. 2003;90:999–1003. CrossRef
- Willett CG, Badizadegan K, Ancukiewicz M, Shellito PC. Prognostic factors in stage T3N0 rectal cancer: do all patients require postoperative pelvic irradiation and chemotherapy? Dis Colon Rectum. 1999;42:167–73. CrossRef
- Gunderson LL, Sargent DJ, Tepper JE, et al. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol. 2004;22:1785–96. CrossRef
- Medical Research Council Rectal Cancer Working Party. Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Lancet. 1996;348:1605–10. CrossRef
- Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638–46. CrossRef
- Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med. 1997;336:980–7. CrossRef
- Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731–40. CrossRef
- Gérard JP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent flurouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol. 2006;24:4620–5. CrossRef
- Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006;355:1114–23. CrossRef
- Sebag-Montefiore D, Stephens R, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373:811–20. CrossRef
- Hildebrandt U, Feifel G. Preoperative staging of rectal cancer by intrarectal ultrasound. Dis Colon Rectum. 1985;28:42–6. CrossRef
- Beets-Tan RGH, Beets GL, Vliegen RFA, et al. Accuracy of magnetic resonance imaging in prediction of tumor-free resection margin in rectal cancer surgery. Lancet. 2001;357:497–504. CrossRef
- Brown G, Richards CJ, Bourne MW, et al. Morphological predictors of lymph node status in rectal cancer using high spatial resolution magnetic resonance imaging with histopathological comparison. Radiology. 2003;227:371–7. CrossRef
- AJCC Cancer Staging Manual, 5th ed. Philadelphia: Lippincott-Raven, 1998.
- Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997;12:19–23. CrossRef
- Guillem JG, Diaz-Gonzalez JA, Minsky BD, et al. CT3N0 rectal cancer: Potential overtreatment with preoperative chemoradiation is warranted. J Clin Oncol. 2008;26:368–73. CrossRef
- Bipat S, Glas AS, Slors FJ, et al. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MRI—a meta-analysis. Radiology. 2004;232:773–83. CrossRef
- Dworak O. Morphology of lymph nodes in the resected rectum of patients with rectal carcinoma. Pathol Res Pract. 1991;187:1020–4.
- Brown G, Radcliffe AG, Newcombe RG, et al. Preoperative assessment of prognostic factors in rectal cancer using high resolution magnetic resonance imaging. Br J Surg. 2003;90:355–64. CrossRef
- MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ. 2006;333:779.
- Koh DM, Brown G, Temple L, et al. Rectal cancer: mesorectal lymph nodes at MRI with USPIO versus histopathologic findings—initial observations. Radiology. 2004;231:91–9. CrossRef
- Kim JC, Kim HC, Yu CS, et al. Efficacy of 3-dimensional endorectal ultrasonography compared with conventional ultrasonography and computed tomography in preoperative rectal cancer staging. Am J Surg. 2006;192:89–97. CrossRef
- Filippone A, Ambrosini R, Fuschi M, et al. Preoperative T and N staging of colorectal cancer: accuracy of contrast-enhanced multi-detector row colonography—initial experience. Radiology. 2004;231:83–90. CrossRef
- Wibe A, Rendedal PR, Svensson E, et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg. 2002;89:327–34. CrossRef
- Park IJ, Kim HC, Yu CS, et al. Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer. Ann Surg Oncol. 2008;15:519–25. CrossRef
- Picon AI, Moore HG, Sternberg SS, et al. Prognostic significance of depth of gross or microscopic perirectal fat invasion in T3 N0 M0 rectal cancers following sharp mesorectal excision and no adjuvant therapy. Int J Colorectal Dis. 2003;18:487–92. CrossRef
- Steel MCA, Woods R, Mackay JM, Chen F. Extent of mesorectal invasion is a prognostic indicator in T3 rectal carcinoma. ANZ J Surg. 2002;72:483–7. CrossRef
- Nissan A, Stojadinovic A, Shia J, et al. Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery alone. J Clin Oncol. 2006;24:4078–84. CrossRef
- Peeters KCMJ, Marijnen CAM, Nagtegaal ID, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007;246:693–701. CrossRef
- Bosset JF, Calais G, Daban A, et al. Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance—report of the 22921 randomized trial conducted by the EORTC Radiotherapy Group. Eur J Cancer. 2004;40:219–24. CrossRef
- Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg. 2006;93:1215–23. CrossRef
- Mohiuddin M, Marks J, Marks G. Management of rectal cancer: short- vs. long-course preoperative radiation. Int J Radiat Oncol Biol Phys. 2008;72:636–43.
- Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol. 2008;26:303–12. CrossRef
- Wichmann MW, Muller C, Meyer G, et al. Effect of preoperative radiochemotherapy on lymph node retrieval after resection of rectal cancer. Arch Surg. 2002;137:206–10. CrossRef
- Beresford M, Glynne-Jones R, Richman P, et al. The reliability of lymph-node staging in rectal cancer after preoperative chemoradiotherapy. Clin Oncol. 2005;17:448–55. CrossRef
- Habr-Gama A, Perez RO, Proscurshim I, et al. Absence of lymph nodes in the resected specimen after radical surgery for distal rectal cancer and neoadjuvant chemoradiation therapy: what does it mean? Dis Colon Rectum. 2008;51:277–83. CrossRef
- Clinically-Staged T3N0 Rectal Cancer: Is Preoperative Chemoradiotherapy the Optimal Treatment?
Annals of Surgical Oncology
Volume 17, Issue 3 , pp 838-845
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Raffaele Lombardi MD (1)
- Dajana Cuicchi MD (1)
- Carmine Pinto MD (2)
- Francesca Di Fabio MD (2)
- Bruno Iacopino MD (3)
- Stefano Neri MD (3)
- Maria Lucia Tardio MD (4)
- Claudio Ceccarelli PhD (4)
- Ferdinando Lecce MD (1)
- Giampaolo Ugolini MD (1)
- Sara Pini MD (2)
- Piergiorgio Di Tullio MD (2)
- Mario Taffurelli MD (1)
- Francesco Minni MD (1)
- Andrea Martoni MD (2)
- Bruno Cola MD, FACS (1)
- Author Affiliations
- 1. General Surgery Unit, S.Orsola-Malpighi Hospital, Bologna, Italy
- 2. Medical Oncology Unit, S.Orsola-Malpighi Hospital, Bologna, Italy
- 3. Radiotherapy Unit, S.Orsola-Malpighi Hospital, Bologna, Italy
- 4. Pathology Unit, S.Orsola-Malpighi Hospital, Bologna, Italy